Corrigendum to Immunotherapy to reduce frequency of urinary tract infections in people with neurogenic bladder dysfunction; a pilot randomised, placebo-controlled trial.
Wade DT, Cooper J, Peckham N, Belci M. Immunotherapy to reduce frequency of urinary tract infections in people with neurogenic bladder dysfunction; a pilot randomised, placebo-controlled trial. Clinical Rehabilitation. 2020;34(12):1458–1464. doi:10.1177/0269215520946065
The authors unreservedly apologise for failing to include acknowledgements to individuals who were involved with the research to a greater or lesser extent. They acknowledge the contributions made by:
Dr. Joost van Middendorp and Dr. Harriet Allison (both Stoke Mandeville Spinal Research) for their work on the initial concept of the project and successfully securing funding from the NIHR.
The late Professor Paul Kennedy, and Dr. Sen Selvarajah (both at Buckinghamshire Healthcare NHS Trust) and Dr. Jasmine Hearn (University of Buckingham) for their work on the early stages of the project.
Dr. Julian Taylor for setting up and being part of the Trial Steering Committee and the Trial Management Group
Mr. Nigel Henderson and the team at the Oxford Clinical Trials Research Unit for their support and guidance.